Table 4.
N = 89 | ||
---|---|---|
Parameter (preferred terms) | n (%) | Number of events |
Any SAE | 69 (77.5) | 254 |
Pyrexia | 25 (28.1) | 36 |
Device‐related infectiona | 24 (27.0) | 36 |
Influenza | 9 (10.1) | 9 |
Device breakagea | 8 (9.0) | 9 |
Dehydration | 7 (7.9) | 12 |
Upper respiratory tract infection | 6 (6.7) | 6 |
SAE, serious adverse event.
aAll device‐related events were related to central venous catheters used to administer parenteral support, not to the teduglutide injection device.